Key result
In murine ventricular myocytes, the P2X agonist 2-meSATP increased peak Na+-K+-ATPase current from 0.52 to 0.58 pA/pF, demonstrating a novel Na+ entry pathway through ligand-gated P2X4Rs.
Why the study?
Does P2X receptor activation by 2-meSATP modulate Na+ handling and contractility in adult murine cardiac ventricular myocytes?
Does P2X receptor activation by 2-meSATP modulate Na+ handling and contractility in adult murine cardiac ventricular myocytes?
Absolute Event Rate: 0.58% vs 0.52%
Cardiac P2X4 receptors constitute a novel Na+ entry pathway that stimulates the Ca2+ entry mode of the Na+/Ca2+ exchanger to enhance cardiomyocyte contractility.
P2X4R activation may enhance murine myocyte contractility; hypothesis-generating for human HF therapies, requiring validation before any clinical consideration.
P2X4 receptors (P2X4Rs) are ligand-gated ion channels capable of conducting cations such as Na(+). Endogenous cardiac P2X4R can mediate ATP-activated current in adult murine cardiomyocytes. In the present study, we tested the hypothesis that cardiac P2X receptors can induce Na(+) entry and modulate Na(+) handling. We further determined whether P2X receptor-induced stimulation of the Na(+)/Ca(2+) exchanger (NCX) has a role in modulating the cardiac contractile state. Changes in Na(+)-K(+)-ATPase current (Ip) and NCX current (INCX) after agonist stimulation were measured in ventricular myocytes of P2X4 transgenic mice using whole cell patch-clamp techniques. The agonist 2-methylthio-ATP (2-meSATP) increased peak Ip from a basal level of 0.52 ± 0.02 to 0.58 ± 0.03 pA/pF. 2-meSATP also increased the Ca(2+) entry mode of INCX (0.55 ± 0.09 pA/pF under control conditions vs. 0.82 ± 0.14 pA/pF with 2-meSATP) at a membrane potential of +50 mV. 2-meSATP shifted the reversal potential of INCX from -14 ± 2.3 to -25 ± 4.1 mV, causing an estimated intracellular Na(+) concentration increase of 1.28 ± 0.42 mM. These experimental results were closely mimicked by mathematical simulations based on previously established models. KB-R7943 or a structurally different agent preferentially opposing the Ca(2+) entry mode of NCX, YM-244769, could inhibit the 2-meSATP-induced increase in cell shortening in transgenic myocytes. Thus, the Ca(2+) entry mode of INCX participates in P2X agonist-stimulated contractions. In ventricular myocytes from wild-type mice, the P2X agonist could increase INCX, and KB-R7943 was able to inhibit the contractile effect of endogenous P2X4Rs, indicating a physiological role of these receptors in wild-type cells. The data demonstrate a novel Na(+) entry pathway through ligand-gated P2X4Rs in cardiomyocytes.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2014) studied this question. 2-methylthio-ATP (2-meSATP) vs. Basal level / control conditions was evaluated on Peak Na+-K+-ATPase current (Ip). In murine ventricular myocytes, the P2X agonist 2-meSATP increased peak Na+-K+-ATPase current from 0.52 to 0.58 pA/pF, demonstrating a novel Na+ entry pathway through ligand-gated P2X4Rs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: